{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T18:06:58Z","timestamp":1774894018630,"version":"3.50.1"},"reference-count":28,"publisher":"Japan Endocrine Society","issue":"11","funder":[{"DOI":"10.13039\/100015993","name":"Kowa Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015993","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Japan Agency for Medic al Research and Development","award":["J230705536"],"award-info":[{"award-number":["J230705536"]}]},{"name":"the Japan Society for the Promotion of Science (JSPS) KAKENHI","award":["21K08323"],"award-info":[{"award-number":["21K08323"]}]},{"name":"the Japan Society for the Promotion of Science (JSPS) KAKENHI","award":["22H02967"],"award-info":[{"award-number":["22H02967"]}]},{"name":"the Japan Society for the Promotion of Science (JSPS) KAKENHI","award":["22K08670"],"award-info":[{"award-number":["22K08670"]}]},{"name":"the Japan Society for the Promotion of Science (JSPS) KAKENHI","award":["23K07968"],"award-info":[{"award-number":["23K07968"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2024]]},"DOI":"10.1507\/endocrj.ej24-0087","type":"journal-article","created":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T22:11:27Z","timestamp":1725919887000},"page":"1055-1067","source":"Crossref","is-referenced-by-count":2,"title":["Tofogliflozin attenuates renal lipid deposition and inflammation &lt;i&gt;via&lt;\/i&gt; PPAR\u03b1 upregulation mediated by miR-21a impairment in diet-induced steatohepatitic mice"],"prefix":"10.1507","volume":"71","author":[{"given":"Sae","family":"Nishihara","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan"},{"name":"Department of Clinical Laboratory and Biomedical Sciences, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1852-9319","authenticated-orcid":false,"given":"Masahiro","family":"Koseki","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsunao","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Omatsu","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayami","family":"Saga","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Sawabe","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyasu","family":"Inui","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Okada","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tohru","family":"Ohama","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4552-783X","authenticated-orcid":false,"given":"Daisuke","family":"Okuzaki","sequence":"additional","affiliation":[{"name":"Genome Information Research Center, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Kamada","sequence":"additional","affiliation":[{"name":"Department of Advanced Metabolic Hepatology, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafumi","family":"Ono","sequence":"additional","affiliation":[{"name":"Division of Innovative Medicine for Hepatobiliary &amp; Pancreatology, Faculty of Medicine, Kagawa University, Kagawa 761-0793, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Nishida","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan"},{"name":"Health Care Division, Health and Counseling Center, Osaka University, Osaka 565-0871, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5971-9296","authenticated-orcid":false,"given":"Mikio","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory and Biomedical Sciences, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Sakata","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY (2004) Chronic kidney disease and the risks of death cardiovascular events and hospitalization. N Engl J Med 351: 1296\u20131305.","DOI":"10.1056\/NEJMoa041031"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Herman-Edelstein M, Scherzer P, Tobar A, Levi M, Gafter U (2014) Altered renal lipid metabolism and renal lipid accumulation in human diabetic nephropathy. J Lipid Res 55: 561\u2013572.","DOI":"10.1194\/jlr.P040501"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Kang HM, Ahn SH, Choi P, Ko YA, Han SH, et al. (2015) Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development. Nat Med 21: 37\u201346.","DOI":"10.1038\/nm.3762"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Heerspink HJL, Stefansson BV, Correa-Rotter R, Chertow GM, Greene T, et al. (2020) Dapagliflozin in patients with chronic kidney disease. N Engl J Med 383: 1436\u20131446.","DOI":"10.1056\/NEJMoa2024816"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 The EMPA-KIDNEY Collaborative Group; Herrington WG, Staplin N, Wanner C, Green JB, et al. (2023) Empagliflozin in patients with chronic kidney disease. N Engl J Med 388: 117\u2013127.","DOI":"10.1056\/NEJMoa2204233"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6 Cherney DZ, Perkins BA, Soleymanlou N, Maione M, Lai V, et al. (2014) Renal hemodynamic effect of sodium-glucose cotransporter 2 inhibition in patients with type 1 diabetes mellitus. Circulation 129: 587\u2013597.","DOI":"10.1161\/CIRCULATIONAHA.113.005081"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 O\u2019Neill J, Fasching A, Pihl L, Patinha D, Franzen S, et al. (2015) Acute SGLT inhibition normalizes O2 tension in the renal cortex but causes hypoxia in the renal medulla in anaesthetized control and diabetic rats. Am J Physiol Renal Physiol 309: F227\u2013F234.","DOI":"10.1152\/ajprenal.00689.2014"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Tomita I, Kume S, Sugahara S, Osawa N, Yamahara K, et al. (2020) SGLT2 inhibition mediates protection from diabetic kidney disease by promoting ketone body-induced mTORC1 inhibition. Cell Metab 32: 404\u2013419.e6.","DOI":"10.1016\/j.cmet.2020.06.020"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Chang J, Koseki M, Saga A, Kanno K, Higo T, et al. (2020) Dietary oxysterol, 7-ketocholesterol accelerates hepatic lipid accumulation and macrophage infiltration in obese mice. Front Endocrinol (Lausanne) 11: 614692.","DOI":"10.3389\/fendo.2020.614692"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Kanno K, Koseki M, Chang J, Saga A, Inui H, et al. (2022) Pemafibrate suppresses NLRP3 inflammasome activation in the liver and heart in a novel mouse model of steatohepatitis-related cardiomyopathy. Sci Rep 12: 2996.","DOI":"10.1038\/s41598-022-06542-8"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Saga A, Koseki M, Kanno K, Chang J, Higo T, et al. (2022) A dietary oxysterol, 7-ketocholesterol, exacerbates imiquimod-induced psoriasis-like dermatitis in steatohepatitic mice. Int J Mol Sci 23: 15855.","DOI":"10.3390\/ijms232415855"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Targher G, Bertolini L, Rodella S, Zoppini G, Lippi G, et al. (2008) Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative\/laser-treated retinopathy in type 2 diabetic patients. Diabetologia 51: 444\u2013450.","DOI":"10.1007\/s00125-007-0897-4"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Kim D, Pertea G, Trapnell C, Pimentel H, Kelley R, et al. (2013) TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol 14: R36.","DOI":"10.1186\/gb-2013-14-4-r36"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Langmead B, Salzberg SL (2012) Fast gapped-read alignment with Bowtie 2. Nat Methods 9: 357\u2013359.","DOI":"10.1038\/nmeth.1923"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Bonfield JK, Marshall J, Danecek P, Li H, Ohan V, et al. (2021) HTSlib: C library for reading\/writing high-throughput sequencing data. Gigascience 10: giab007.","DOI":"10.1093\/gigascience\/giab007"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Trapnell C, Williams BA, Pertea G, Mortazavi A, Kwan G, et al. (2010) Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol 28: 511\u2013515.","DOI":"10.1038\/nbt.1621"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17 Schroder K, Tschopp J (2010) The inflammasomes. Cell 140: 821\u2013832.","DOI":"10.1016\/j.cell.2010.01.040"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Chau BN, Xin C, Hartner J, Ren S, Castano AP, et al. (2012) MicroRNA-21 promotes fibrosis of the kidney by silencing metabolic pathways. Sci Transl Med 4: 121ra118.","DOI":"10.1126\/scitranslmed.3003205"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Liu X, Guo JW, Lin XC, Tuo YH, Peng WL, et al. (2021) Macrophage NFATc3 prevents foam cell formation and atherosclerosis: evidence and mechanisms. Eur Heart J 42: 4847\u20134861.","DOI":"10.1093\/eurheartj\/ehab660"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Chan JA, Krichevsky AM, Kosik KS (2005) MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 65: 6029\u20136033.","DOI":"10.1158\/0008-5472.CAN-05-0137"},{"key":"21","doi-asserted-by":"publisher","unstructured":"21 Thum T, Gross C, Fiedler J, Fischer T, Kissler S, et al. (2008) MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 456: 980\u2013984.","DOI":"10.1038\/nature07511"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Das NA, Carpenter AJ, Belenchia A, Aroor AR, Noda M, et al. (2020) Empagliflozin reduces high glucose-induced oxidative stress and miR-21-dependent TRAF3IP2 induction and RECK suppression, and inhibits human renal proximal tubular epithelial cell migration and epithelial-to-mesenchymal transition. Cell Signal 68: 109506.","DOI":"10.1016\/j.cellsig.2019.109506"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Cheng Y, Wang D, Wang F, Liu J, Huang B, et al. (2020) Endogenous miR-204 protects the kidney against chronic injury in hypertension and diabetes. J Am Soc Nephrol 31: 1539\u20131554.","DOI":"10.1681\/ASN.2019101100"},{"key":"24","doi-asserted-by":"publisher","unstructured":"24 Tontonoz P, Nagy L, Alvarez JG, Thomazy VA, Evans RM (1998) PPARgamma promotes monocyte\/macrophage differentiation and uptake of oxidized LDL. Cell 93: 241\u2013252.","DOI":"10.1016\/S0092-8674(00)81575-5"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 van der Lee KA, Vork MM, De Vries JE, Willemsen PH, Glatz JF, et al. (2000) Long-chain fatty acid-induced changes in gene expression in neonatal cardiac myocytes. J Lipid Res 41: 41\u201347.","DOI":"10.1016\/S0022-2275(20)32072-1"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Qiao L, Zou C, Shao P, Schaack J, Johnson PF, et al. (2008) Transcriptional regulation of fatty acid translocase\/CD36 expression by CCAAT\/enhancer-binding protein alpha. J Biol Chem 283: 8788\u20138795.","DOI":"10.1074\/jbc.M800055200"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Bastie CC, Nahle Z, McLoughlin T, Esser K, Zhang W, et al. (2005) FoxO1 stimulates fatty acid uptake and oxidation in muscle cells through CD36-dependent and -independent mechanisms. J Biol Chem 280: 14222\u201314229.","DOI":"10.1074\/jbc.M413625200"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Wu H, Ng R, Chen X, Steer CJ, Song G (2016) MicroRNA-21 is a potential link between non-alcoholic fatty liver disease and hepatocellular carcinoma <i>via<\/i> modulation of the HBP1-p53-Srebp1c pathway. Gut 65: 1850\u20131860.","DOI":"10.1136\/gutjnl-2014-308430"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/71\/11\/71_EJ24-0087\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,2]],"date-time":"2024-11-02T04:38:21Z","timestamp":1730522301000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/71\/11\/71_EJ24-0087\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":28,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej24-0087","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]},"article-number":"EJ24-0087"}}